Selective molecular inhibition of the HDAC6 ZnF-UBP binding domain impairs multiple myeloma cell function

Abstract Multiple myeloma is a plasma cell malignancy with a poor prognosis despite the recent development of new therapeutic options. Histone deacetylase 6 (HDAC6) is overexpressed in multiple myeloma cells and may be involved in the acquisition of resistance to conventional anti-proteasome treatme...

Full description

Saved in:
Bibliographic Details
Main Authors: Rafael Rincón, Isabel F. Coira, Antoine Richieu, Fedaa Attana, Muriel Urwyler, Shozeb Haider, Carole Bourquin, Philippe Bertrand, Muriel Cuendet
Format: Article
Language:English
Published: Nature Publishing Group 2025-04-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02465-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items